Pulmonx Corp (NAS:LUNG)

$ 6.3 -0.16 (-2.48%) Market Cap: 248.77 Mil Enterprise Value: 196.80 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 56/100

Q3 2024 Pulmonx Corp Earnings Call Transcript
Oct 30, 2024

$6.79 (+0.30%)

Earnings
Q2 2024 Pulmonx Corp Earnings Call Transcript
Jul 31, 2024

$6.91 (-2.12%)

Earnings
Q1 2024 Pulmonx Corp Earnings Call Transcript
May 01, 2024

$7.72 (+1.45%)

Earnings
Q4 2023 Pulmonx Corp Earnings Call Transcript
Feb 21, 2024

$14.5 (+0.62%)

Earnings
Q3 2023 Pulmonx Corp Earnings Call Transcript
Oct 30, 2023

$7.89 (-4.01%)

Earnings
Q2 2023 Pulmonx Corp Earnings Call Transcript
Aug 02, 2023

$13.23 (-4.20%)

Earnings
Pulmonx Corp at Bank of America Global Healthcare Conference Transcript
May 09, 2023
Q1 2023 Pulmonx Corp Earnings Call Transcript
May 02, 2023

$11.47 (-6.90%)

Earnings
Pulmonx Corp at Citi Healthcare & Medtech Conference Transcript
Mar 02, 2023
Q4 2022 Pulmonx Corp Earnings Call Transcript
Feb 22, 2023

$8.76 (+0.46%)

Earnings
Q3 2022 Pulmonx Corp Earnings Call Transcript
Nov 03, 2022

$12.34 (-9.53%)

Earnings
Pulmonx Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Pulmonx Corp Earnings Call Transcript
Aug 02, 2022

$18.48 (+5.60%)

Earnings
Pulmonx Corp at Bank of America Healthcare Conference Transcript
May 10, 2022
Q1 2022 Pulmonx Corp Earnings Call Transcript
May 03, 2022

$25.34 (+1.04%)

Earnings
Pulmonx Corp at Citi Healthcare Conference (Virtual) Transcript
Feb 24, 2022
Q4 2021 Pulmonx Corp Earnings Call Transcript
Feb 23, 2022

$26.25 (-2.56%)

Earnings
Pulmonx Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2022
Q3 2021 Pulmonx Corp Earnings Call Transcript
Nov 02, 2021

$39.72 (-0.80%)

Earnings
Pulmonx Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021
Q2 2021 Pulmonx Corp Earnings Call Transcript
Aug 03, 2021

$39.19 (-2.59%)

Earnings
Pulmonx Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021
Q1 2021 Pulmonx Corp Earnings Call Transcript
May 04, 2021

$46.88 (-0.45%)

Earnings
Q4 2020 Pulmonx Corp Earnings Call Transcript
Mar 02, 2021

$58.05 (-3.52%)

Earnings
Q3 2020 Pulmonx Corp Earnings Call Transcript
Nov 10, 2020

$46.33 (-3.70%)

Earnings

Pulmonx Corp at Citi Healthcare & Medtech Conference Transcript

Mar 02, 2023 / 06:15PM GMT

Release Date Price: $11.39 (-0.78%)

Transcript 10-K

Joanne Karen Wuensch

Citigroup Inc., Research Division - MD

So the music has died down, which tells me, it's time for us to start the next presentation. I am still Joanne Wuensch from Citibank. And this time, we have with us the management team from Pulmonx. So welcome to New York City.

Glendon E. French

Pulmonx Corporation - CEO, President & Director

Thank you for having us.

Questions & Answers

Joanne Karen Wuensch;Glendon E. French

Citigroup Inc., Research Division - MD;Pulmonx Corporation - CEO, President &

It's interesting as I try to follow or I do follow the Zephyr Valve launch and uptake. And we've spent a fair amount of time talking about the eases or obstacles to product adoption, particularly launching a new product during the pandemic. So I'd like to sort of start our conversation today from a big picture vantage point. Where are we in terms of the product launch? And where are you maybe in terms of moving some of those obstacles out of the way.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.